File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Liver transplantation for hepatitis B virus-related hepatocellular carcinoma in Hong Kong

TitleLiver transplantation for hepatitis B virus-related hepatocellular carcinoma in Hong Kong
Authors
KeywordsLiver transplantation
Hepatitis B
Hepatocellular carcinoma
Review
Issue Date2018
PublisherXia & He Publishing. The Journal's web site is located at http://www.xiahepublishing.com/2310-8819/Journal.aspx?sid=2
Citation
Journal of Clinical and Translational Hepatology, 2018, v. 6 n. 3, p. 283-288 How to Cite?
AbstractHepatocellular carcinoma (HCC) is the fifth most common cancer and the third most common cause of cancer-related deaths worldwide. Curative resection is frequently limited in Hong Kong by hepatitis B virus-related cirrhosis, and liver transplantation is the treatment of choice. Liver transplantation has been shown to produce superior oncological benefits, when compared to hepatectomy for HCC. New developments in the context of patient selection criteria, modification of organ allocation, bridging therapy, salvage liver transplantation and pharmaceutical breakthrough have improved the survival of HCC patients. In this article, we will share our experience in transplanting hepatitis B virus-related HCC patients in Hong Kong and discuss the recent progress in several areas of liver transplantation.
Persistent Identifierhttp://hdl.handle.net/10722/271253
ISSN
2023 Impact Factor: 3.1
2023 SCImago Journal Rankings: 0.988
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorMa, KW-
dc.contributor.authorChok, KSH-
dc.contributor.authorFung, JYY-
dc.contributor.authorLo, CM-
dc.date.accessioned2019-06-24T01:06:19Z-
dc.date.available2019-06-24T01:06:19Z-
dc.date.issued2018-
dc.identifier.citationJournal of Clinical and Translational Hepatology, 2018, v. 6 n. 3, p. 283-288-
dc.identifier.issn2225-0719-
dc.identifier.urihttp://hdl.handle.net/10722/271253-
dc.description.abstractHepatocellular carcinoma (HCC) is the fifth most common cancer and the third most common cause of cancer-related deaths worldwide. Curative resection is frequently limited in Hong Kong by hepatitis B virus-related cirrhosis, and liver transplantation is the treatment of choice. Liver transplantation has been shown to produce superior oncological benefits, when compared to hepatectomy for HCC. New developments in the context of patient selection criteria, modification of organ allocation, bridging therapy, salvage liver transplantation and pharmaceutical breakthrough have improved the survival of HCC patients. In this article, we will share our experience in transplanting hepatitis B virus-related HCC patients in Hong Kong and discuss the recent progress in several areas of liver transplantation.-
dc.languageeng-
dc.publisherXia & He Publishing. The Journal's web site is located at http://www.xiahepublishing.com/2310-8819/Journal.aspx?sid=2-
dc.relation.ispartofJournal of Clinical and Translational Hepatology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectLiver transplantation-
dc.subjectHepatitis B-
dc.subjectHepatocellular carcinoma-
dc.subjectReview-
dc.titleLiver transplantation for hepatitis B virus-related hepatocellular carcinoma in Hong Kong-
dc.typeArticle-
dc.identifier.emailChok, KSH: chok6275@hku.hk-
dc.identifier.emailFung, JYY: jfung@hkucc.hku.hk-
dc.identifier.emailLo, CM: chungmlo@hkucc.hku.hk-
dc.identifier.authorityChok, KSH=rp02110-
dc.identifier.authorityFung, JYY=rp00518-
dc.identifier.authorityLo, CM=rp00412-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.14218/JCTH.2017.00058-
dc.identifier.pmid30271740-
dc.identifier.pmcidPMC6160307-
dc.identifier.scopuseid_2-s2.0-85090329190-
dc.identifier.hkuros297995-
dc.identifier.volume6-
dc.identifier.issue3-
dc.identifier.spage283-
dc.identifier.epage288-
dc.identifier.isiWOS:000447465800007-
dc.publisher.placeUnited States-
dc.identifier.issnl2225-0719-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats